SMMT icon

Summit Therapeutics
SMMT

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $4.75M invested in Summit Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

1.89% less ownership

Funds ownership: 3.51% → 1.62% (-1.9%)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$180K
2
+$49.9K
3
+$39.7K
4
Deutsche Bank
Deutsche Bank
Germany
+$21K
5
VF
Virtu Financial
New York
+$20K

Top Sellers

1
-$513K
2
-$14K
3
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.92M
2
$641K
3
$417K
4
$321K
5
$180K
6
$140K
7
$44K
8
$41K
9
$21K
10
$20K
11
$1K
12
$1K
13
$1K
14
–
15
–